Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2011-10-13

Clinical Trial Update: Inhaled Glutathione (GSH) Versus Placebo in Cystic Fibrosis [Phase 3]

View source ↗

Summary

Phase 3 clinical trial comparing inhaled glutathione (GSH) to placebo in cystic fibrosis; the current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Glutathione (glutathione)

Snippet

Sponsor: Serafino A. Marsico | Conditions: Cystic Fibrosis | Phase 3 | Status: UNKNOWN